Rapid7 reports Q1 2026 results on May 7 against a backdrop of rising short pressure, beaten-down analyst targets, and a stock that has lost more than half its value this year.
Short sellers have grown more aggressive in the final stretch before the print. Short interest climbed to 10.7% of the free float as of May 4, up roughly 9% in both the past day and the past week — the sharpest acceleration in the 30-day window. The ORTEX short score jumped to 53.5 on May 4 from 45.7 a week earlier, its highest reading in the tracked history. Borrow remains cheap at 0.44% despite this build, though availability has tightened sharply: the ratio of shares available to borrow versus those already borrowed hit a new 52-week low of roughly 7% on May 4, compared with a reading above 700% less than two months ago. That compression points to real incremental demand for the borrow, not simply passive drift.
The options market tells a less urgent story. The put/call ratio runs at 0.74, only half a standard deviation above its 20-day average of 0.70, and well below the 52-week high of 0.97. Options traders are not in panic mode. The stock itself has recovered 25% from its lows over the past month, including a 15% bounce last week, closing at $6.68 — though it remains down 58% year-to-date.
The analyst community has been decisively negative since the February earnings collapse, when the stock fell 32% in a single session. JPMorgan, Barclays, Citigroup, Piper Sandler and RBC all cut targets sharply on February 11-12, while Canaccord downgraded outright. More recently, William Blair downgraded to Market Perform on April 29 and Truist cut its target to $6 — below the current price. The consensus mean target of $8.84 still implies meaningful upside from $6.68, but the direction of travel has been one-way lower. Bears point to a leadership transition, execution uncertainty in the Risk and Exposure Management segment, and near-term margin pressure from AI investment. Bulls see a cybersecurity platform with credible AI integration potential, improving operational discipline, and a stock trading at just 6.6x EV/EBITDA — a discount to software peers.
One institutional angle stands out: activist Jana Partners Management holds 10.2% of shares, unchanged in its most recent filing, and has board representation. The 90-day insider net balance is marginally positive, but that figure is distorted by the Jana board position — operating-level executives have been net sellers throughout the period, including the CEO in February.
The May 7 print is less a verdict on Rapid7's long-term cybersecurity positioning and more a test of whether management can deliver guidance that stabilises expectations after the brutal reset three months ago.
See the live data behind this article on ORTEX.
Open RPD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
